Jonathan Lee

Jonathan Lee

Auto-generated profile, based on publicly available information

Jonathan Lee

Department of Orthopaedic Surgery, Stanford University, Redwood City, California, USA, stanford.edu

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2018 in Circulation: Cardiovascular Imaging
Verified
Journal Article
Closed access
JCJulio A. Chirinos
Julio A. Chirinos
MSMayank Sardana
Mayank Sardana
BABilal Ansari
Bilal Ansari
VSVaibhav Satija
Vaibhav Satija
DKDaniel Kuriakose
Daniel Kuriakose
SAScott R. Akers
Scott R. Akers
Background: The prognostic importance of left atrial (LA) dysfunction is increasingly recognized. Magnetic resonance imaging can provide excellent visualization of the LA wall. We aimed to study the association of LA dysfunction measured using feature-tracking magnetic resonance imaging with incident adverse cardiovascular events among subjects with or without heart failure (HF) at baseline. Methods and Results: We prospectively studied 640 adults without HF (n=419), HF with preserved ejection fraction (n=101), or HF with reduced ejection fraction (n=120). We measured phasic LA function by volumetric and feature-tracking methods to derive longitudinal strain. The composite outcome of incident HF hospitalization or death was adjudicated during a median follow-up of 37.1 months. Measures of LA phasic function were more prominently impaired in subjects with HF with reduced ejection fraction than among subjects with HF with preserved ejection fraction. In unadjusted Cox proportional hazards models, all measures of phasic LA function and volumes (maximum, minimum, and diastatic) were associated with the composite outcome. However, in analyses that adjusted for clinical risk factors, HF status, maximum LA volume, left ventricular mass, and left ventricular ejection fraction, measures of conduit and reservoir LA function, but not booster-pump function, were associated with the composite outcome. The strongest associations were observed for conduit longitudinal strain (standardized hazard ratio, 0.66; 95% CI, 0.49–0.88; P =0.004), conduit strain rate (standardized hazard ratio, 1.59; 95% CI, 1.16–2.16; P =0.0035), and reservoir strain (standardized hazard ratio, 0.68; 95% CI, 0.52–0.89; P =0.0055). Conclusions: Phasic LA function measured using magnetic resonance imaging feature tracking is independently predictive of the risk of incident HF admission or death, even after adjusting for LA volume and left ventricular remodeling.

1 August 2019 in JACC: Cardiovascular Imaging
Verified
Journal Article
Closed access
SJSnigdha Jain
Snigdha Jain
DKDaniel Kuriakose
Daniel Kuriakose
IEIlaina Edelstein
Ilaina Edelstein
BABilal Ansari
Bilal Ansari
GOGarrett Oldland
Garrett Oldland
JCJulio A. Chirinos
Julio A. Chirinos

17 May 2018 in American Journal of Hypertension
Verified
Journal Article
Open access
PDF file
HPHoury Puzantian
Houry Puzantian
SAScott R Akers
Scott R Akers
GOGarrett Oldland
Garrett Oldland
KJKhuzaima Javaid
Khuzaima Javaid
RMRachana Miller
Rachana Miller
JCJulio A Chirinos
Julio A Chirinos
Large artery stiffening is increased in advanced chronic kidney disease (CKD) but likely develops progressively in earlier stages of CKD. Active matrix Gla-protein (MGP) is a potent vitamin K–dependent inhibitor of vascular calcification. A recent animal model demonstrated intrinsic abnormalities in vitamin K metabolism even in early CKD, but whether early human CKD is associated with vascular vitamin K deficiency is unknown. We enrolled 137 adults without HF with varying degrees of renal function: normal estimated glomerular filtration rate (eGFR; >90 ml/min; n = 59), mildly reduced eGFR (stage 2 CKD: eGFR = 60–89 ml/min; n = 53) or at least moderately reduced eGFR (stage 3–5 CKD; eGFR < 60 ml/min; n = 25). Carotid-femoral pulse wave velocity (CF-PWV) was measured with carotid and femoral tonometry. Dephospho-uncarboxylated matrix gla-protein (dp-ucMGP) was measured with enzyme-linked immunosorbent assay (ELISA) (VitaK; Maastricht University; The Netherlands). Dp-ucMGP levels were progressively increased with decreasing renal function (eGFR ≥ 90: 247 pmol/l; eGFR 60–89: 488 pmol/l; eGFR < 60: 953 pmol/l; P < 0.0001). These differences persisted after adjustment for multiple potential confounders (eGFR ≥ 90: 314 pmol/l; eGFR 60–89: 414 pmol/l; eGFR < 60: 770 pmol/l; P < 0.0001). In a multivariable model adjusted for various confounders, dp-ucMGP was a significant independent predictor of CF-PWV (β = 0.21; P = 0.019). In formal mediation analyses, dp-ucMGP mediated a significant relationship between eGFR and higher CF-PWV (β = −0.16; P = 0.005), whereas no significant dp-ucMGP–independent relationship was present (β = −0.02; P = 0.80). CKD is associated with increased (inactive) dp-ucMGP, a vitamin K–dependent inhibitor of vascular calcification, which correlates with large artery stiffness. Further studies are needed to assess whether vitamin K2 supplementation represents a suitable therapeutic strategy to prevent or reduce arterial stiffening in CKD.

4 February 2020 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
SPStuart B. Prenner
Stuart B. Prenner
RPRaj Pillutla
Raj Pillutla
SYSowjanya Yenigalla
Sowjanya Yenigalla
SGSowmya Gaddam
Sowmya Gaddam
JLJonathan Lee
Jonathan Lee
JCJulio A. Chirinos
Julio A. Chirinos
Background: Data regarding the phenotypic correlates and prognostic value of albumin in heart failure with preserved ejection fraction (HFpEF) are scarce. The goal of the current study is to determine phenotypic correlates (myocardial hypertrophy, myocardial fibrosis, detailed pulsatile hemodynamics, and skeletal muscle mass) and prognostic implications of serum albumin in HFpEF. Methods and Results: We studied 118 adults with HFpEF. All‐cause death or heart‐failure–related hospitalization was ascertained over a median follow‐up of 57.6 months. We measured left ventricular mass, myocardial extracellular volume, and axial muscle areas using magnetic resonance imaging. Pulsatile arterial hemodynamics were assessed with a combination of arterial tonometry and phase‐contrast magnetic resonance imaging. Subjects with lower serum albumin exhibited a higher body mass index, and a greater proportion of black ethnicity and diabetes mellitus. A low serum albumin was associated with higher myocardial extracellular volume (52.3 versus 57.4 versus 39.3 mL in lowest to highest albumin tertile, respectively; P =0.0023) and greater N‐terminal pro B‐type natriuretic peptide levels, but not with a higher myocardial cellular volume (123 versus 114 versus 102 mL; P =0.13). Lower serum albumin was also associated with an increased forward wave amplitude and markedly increased pulsatile power in the aorta. Serum albumin was a strong predictor of death or heart failure hospitalization even after adjustment for N‐terminal pro B‐type natriuretic peptide levels and the Meta‐Analysis Global Group in Chronic Heart Failure (MAGGIC) risk score (adjusted standardized hazard ratio=0.56; 95% CI=0.37–0.83; P <0.0001). Conclusions: Serum albumin is associated with myocardial fibrosis, adverse pulsatile aortic hemodynamics, and prognosis in HFpEF. This readily available clinical biomarker can enhance risk stratification in HFpEF and identifies a subgroup with specific pathophysiological abnormalities.

19 February 2019 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
AKAnupam Kumar
Anupam Kumar
BABilal A. Ansari
Bilal A. Ansari
JKJessica Kim
Jessica Kim
ASArpita Suri
Arpita Suri
SGSowmya Gaddam
Sowmya Gaddam
JCJulio A. Chirinos
Julio A. Chirinos
Background: The impact of skeletal muscle size, quantified using simple noninvasive images routinely obtained during cardiac magnetic resonance imaging studies on mortality in the heart failure ( HF ) population is currently unknown. Methods and Results: We prospectively enrolled 567 subjects without HF (n=364), with HF with reduced ejection fraction (n=111), or with HF with preserved ejection fraction (n=92), who underwent a cardiac magnetic resonance imaging. Skeletal muscle cross‐sectional area was assessed with manual tracing of major thoracic muscle groups on axial chest magnetic resonance images. Factor analysis was used to identify a latent factor underlying the shared variability in thoracic muscle cross‐sectional area. Cox regression was used to assess the relationship between these measurements and all‐cause mortality (median follow up, 36.4 months). A higher overall thoracic muscle area factor assessed with principal component analysis was independently associated with lower mortality (standardized hazard ratio, 0.51; P <0.0001). The thoracic muscle area factor was predictive of death in subjects with HF with preserved ejection fraction, HF with reduced ejection fraction, and those without HF . Among all muscle groups, the pectoralis major cross‐sectional area was the most representative of overall muscle area and was also the most robust predictor of death. A higher pectoralis major cross‐sectional area predicted a lower mortality (standardized hazard ratio, 0.49; P <0.0001), which persisted after adjustment for various confounders (standardized hazard ratio, 0.55; P =0.0017). Conclusions: Axial muscle size, and in particular smaller size of the pectoralis major, is independently associated with higher risk of mortality in patients with and without HF . Further work should clarify the role of muscle wasting as a therapeutic target in patients with HF .

8 January 2019 in Journal of the American Heart Association
Verified
Journal Article
Open access
JCJulio A. Chirinos
Julio A. Chirinos
SAScott R. Akers
Scott R. Akers
ESErik Schelbert
Erik Schelbert
BSBradley S. Snyder
Bradley S. Snyder
WWWalter R. Witschey
Walter R. Witschey
JCJoão L. Cavalcante
João L. Cavalcante
Background: The role of arterial load in severe aortic stenosis is increasingly recognized. However, patterns of pulsatile load and their implications in this population are unknown. We aimed to assess the relationship between the arterial properties and both (1) left ventricular remodeling and fibrosis and (2) the clinical course of patients with severe aortic stenosis undergoing aortic valve replacement ( AVR ). Methods and Results: We enrolled 38 participants with symptomatic severe aortic stenosis scheduled to undergo surgical AVR . Aortic root characteristic impedance, wave reflections parameters (reflection magnitude, reflected wave transit time), and myocardial extracellular mass were measured with cardiac magnetic resonance imaging and arterial tonometry Cardiac magnetic resonance imaging was repeated at 6 months in 30 participants. A reduction in cellular mass (133.6 versus 113.9 g; P =0.002) but not extracellular mass (42.3 versus 40.6 g; P =0.67) was seen after AVR . Participants with higher extracellular mass exhibited greater reflection magnitude (0.68 versus 0.54; P =0.006) and lower aortic root characteristic impedance (56.3 versus 96.9 dynes/s per cm 5 ; P =0.006). Reflection magnitude was a significant predictor of smaller improvement in the quality of life (Kansas City Cardiomyopathy Questionnaire score) after AVR ( R =−0.51; P =0.0026). The 6‐minute walk distance at 6 months after AVR was positively correlated with the reflected wave transit time ( R =0.52; P =0.01). Conclusions: Consistent with animal studies, arterial wave reflections are associated with interstitial volume expansion in severe aortic stenosis and predict a smaller improvement in quality of life following AVR . Future trials should assess whether wave reflections represent a potential therapeutic target to mitigate myocardial interstitial remodeling and to improve the clinical status of this patient population.